SCHEMBL707746

SCHEMBL707746

CCCC(CC(=O)O)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.71
CHRM1 P11229 1/20 0.71
AKR1A1 P14550 1/20 0.71
CHRM3 P20309 1/20 0.71
HTR2A P28223 1/20 0.71
HTR2C P28335 1/20 0.71
ADRA1A P35348 1/20 0.71
HRH1 P35367 1/20 0.71
DRD3 P35462 1/20 0.71
SLC6A3 Q01959 1/20 0.71
HDAC1 Q13547 1/20 0.71
HDAC2 Q92769 1/20 0.71
FOLH1 Q04609 3/20 0.62
SLC1A3 P43003 2/20 0.54
SLC1A2 P43004 2/20 0.54
SLC1A1 P43005 2/20 0.54
GRIK1 P39086 1/20 0.54
GRIK2 Q13002 1/20 0.54
CA2 P00918 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29109670 1.00 TDP1 (0.71) TDP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL6454152 1.00 TDP1 (0.71) TDP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL28191888 0.98 TDP1 (0.68) TDP1CHRM1AKR1A1CHRM3HTR2A
Water SCHEMBL28136139 0.98 TDP1 (0.68) TDP1CHRM1AKR1A1CHRM3HTR2A
Dimethylamine SCHEMBL27914176 0.93 CHRM1 (0.62) TDP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL4661616 0.91 CHRM1 (0.60) TDP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL9308372 0.91 CHRM1 (0.65) TDP1CHRM1AKR1A1CHRM3HTR2A
Diethylamine SCHEMBL27941540 0.88 CHRM1 (0.56) TDP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL306773 0.86 CA2 (0.68) TDP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL9590977 0.86 CA2 (0.68) TDP1CHRM1AKR1A1CHRM3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 622 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118530440-A Side chain modified aromatic-aliphatic branched copolyester and preparation method thereof 中国科学院青岛生物能源与过程研究所 2024-08-23 CN claimed
CN-118530444-A Polyester material with side chain and branched structure, and preparation method and application thereof 中国科学院青岛生物能源与过程研究所 2024-08-23 CN claimed
CN-117004663-A Method for synthesizing (R) -4-propyldihydrofuran-2 (3 hydrogen) -ketone 上海颐碳化学科技有限公司 2023-11-07 CN claimed
CN-116726185-A Pharmaceutical composition and preparation method and application thereof 国家纳米科学中心 2023-09-12 CN claimed
CN-113125585-B Method for detecting R-4-propyl-dihydrofuran-2-ketone or/and related substances thereof 成都百裕制药股份有限公司 2022-05-24 CN claimed
CN-113125585-A Method for detecting R-4-propyl-dihydrofuran-2-ketone or/and related substances thereof 成都百裕制药股份有限公司 2021-07-16 CN claimed
EP-3688124-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME ExxonMobil Chemical Patents Inc. (US) 2020-08-05 EP claimed
US-10711216-B2 Ester compounds, lubricating oil compositions containing same and processes for making same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-07-14 US claimed
CN-111386331-A Ester compound, lubricating oil composition containing same, and method for producing same 埃克森美孚化学专利公司 2020-07-07 CN claimed
US-20190100710-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same EXXONMOBIL CHEMICAL PATENTS INC. 2019-04-04 US claimed
WO-2007141391-A1 BETULIN DERIVED COMPOUNDS USEFUL AS ANTIPROTOZOAL AGENTS VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) 2007-12-13 WO claimed
WO-2007141390-A1 BETULIN DERIVED COMPOUNDS USEFUL AS ANTIVIRAL AGENTS VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) 2007-12-13 WO claimed
WO-2007141392-A2 COMPOSITIONS COMPRISING BETULONIC ACID VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) 2007-12-13 WO claimed
CN-1269823-C 3, 7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds ASTRAZENECA AB (SE) 2006-08-16 CN claimed
CN-1732264-A Borrelidin-producing polyketide synthases and uses thereof BIOTICA TECH LTD (GB) 2006-02-08 CN claimed
US-20050118673-A1 Process for creating a 3-dimensional configuration on a substrate BEN GURION UNIVERSITY OF THE NEGEV, RESEARCH AND DEVELOPMENT AUTHORITY (IL) 2005-06-02 US claimed
CN-1514837-A 3,7-diazabicyclo [3.3.1] for mulations as anti arhythmiccompounds 2004-07-21 CN claimed
CN-1021772-C Process for preparing trans-cyclopentane-1, 2-dicarboxylic acid MEDICINE INDUSTRY RESEARCH INS (CN) 1993-08-11 CN claimed
US-4174391-A ANIMAL GROWTH REGULATORS MAY & BAKER LIMITED (GB) 1979-11-13 US claimed
US-3962212-A PHOSPHORYLATED CELLULOSE ESTER MEMBRANE FOR USE IN SEPARATION OR CONCENTRATION OF SUBSTANCES SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-06-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10711216-B2 Ester compounds, lubricating oil compositions containing same and processes for making same ELOVL1, NOTUM, ELOVL5 TDP1 1178/4885CHRM1 4303/4885AKR1A1 1315/4885
US-20190100710-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same ELOVL1, NOTUM, ELOVL5 TDP1 1178/4885CHRM1 4303/4885AKR1A1 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.